World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
8936
World Ranking
4153
National Ranking
1894

Peter A. Anton publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter A. Anton sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 150 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter A. Anton D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter A. Anton sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Peter A. Anton is affiliated with the University of California, Los Angeles in the United States. Their research primarily falls within the field of Medicine, with significant contributions to subfields such as Infectious Diseases, Epidemiology, and Virology. Additionally, their work touches on General Health Professions and Hematology.

The scientist's research topics include:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV, Drug Use, Sexual Risk
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • COVID-19 Clinical Research Studies

Peter A. Anton has published several recent papers, including:

  • Receptive anal sex contributes substantially to heterosexually acquired HIV infections among at-risk women in twenty US cities: Results from a modelling analysis, 2020, American Journal of Reproductive Immunology
  • Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01), 2023, The Journal of Infectious Diseases
  • Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis, 2021, AIDS
  • A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study), 2021, AIDS Research and Human Retroviruses
  • Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study, 2022, Communications Medicine

The frequent co-authors collaborating with Peter A. Anton include:

  • Ian McGowan
  • Craig W. Hendrix
  • Namandjé N. Bumpus
  • Ross Cranston
  • Manjula Gunawardana

The most common publication venues for their work are:

  • UNC Libraries
  • American Journal of Reproductive Immunology
  • The Journal of Infectious Diseases
  • AIDS
  • AIDS Research and Human Retroviruses

Best Publications

  • Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects

    Ronald T. Mitsuyasu;Peter A. Anton;Steven G. Deeks;David T. Scadden

  • A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.

    Steven G. Deeks;Bridget Wagner;Peter A. Anton;Ronald T. Mitsuyasu

  • Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis

    Charles N. Bernstein;Leanne L. Seeger;James W. Sayre;Peter A. Anton

  • Patchiness of mucosal inflammation in treated ulcerative colitis: A prospective study

    Charles N. Bernstein;Fergus Shanahan;Peter A. Anton;Wilfred M. Weinstein

  • HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota.

    Ian Howard Mchardy;Xiaoxiao Li;Maomeng Tong;Paul Ruegger

  • A Preponderance of CCR5+CXCR4+ Mononuclear Cells Enhances Gastrointestinal Mucosal Susceptibility to Human Immunodeficiency Virus Type 1 Infection

    Michael A. Poles;Julie Elliott;Philip Taing;Peter A. Anton

  • Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue.

    Peter A. Anton;Julie Elliott;Michael A. Poles;Ian M. McGowan

  • Perceptual responses in patients with inflammatory and functional bowel disease.

    L Chang;J Munakata;E A Mayer;M J Schmulson

  • An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease

    Patricia Rawsthorne;Fergus Shanahan;Neil C Cronin;Peter A Anton

  • Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.

    Martin Cranage;Sally Sharpe;Carolina Herrera;Alethea Cope

  • Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation

    T Goode;J O'Connell;P Anton;H Wong

  • Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF

    Mulugeta Million;Yvette Taché;Peter Anton

  • Use of the location-based social networking application GRINDR as a recruitment tool in rectal microbicide development research.

    Earl R. Burrell;Heather A. Pines;Edward Robbie;Leonardo Coleman

  • A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study

    C. N. Bernstein;L. L. Seeger;P. A. Anton;L. Artinian

  • Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals.

    Michael A. Poles;W. John Boscardin;Julie Elliott;Philip Taing

  • Binding and Transfer of Human Immunodeficiency Virus by DC-SIGN+ Cells in Human Rectal Mucosa

    Kevin B. Gurney;Julie Elliott;Hoorig Nassanian;Carol Song

  • RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Tenofovir 1% Gel Compared with Oral Tenofovir Disoproxil Fumarate

    Peter A. Anton;Ross D. Cranston;Angela Kashuba;Craig W. Hendrix

  • Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation.

    Ian McGowan;Julie Elliott;Marie Fuerst;Philip Taing

  • An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial.

    Douglas L. Seidner;Bret A. Lashner;Aaron Brzezinski;Phillip L.C. Banks

  • Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides.

    Patricia S Fletcher;Julie Elliott;Jean-Charles Grivel;Leonid Margolis

  • Human Immunodeficiency Virus Type 1 Infection Is Associated with Significant Mucosal Inflammation Characterized by Increased Expression of CCR5, CXCR4, and β-Chemokines

    Jenny Olsson;Michael Poles;Anna-Lena Spetz;Julie Elliott

  • Prolonged survival and tissue trafficking following adoptive transfer of CD 4 z gene-modified autologous CD 4 1 and CD 8 1 T cells in human immunodeficiency virus – infected subjects

    Unknown

Frequent Co-Authors

Fergus Shanahan
Fergus Shanahan National University of Ireland
Otto O. Yang
Otto O. Yang University of California, Los Angeles
Beth D. Jamieson
Beth D. Jamieson University of California, Los Angeles
Emeran A. Mayer
Emeran A. Mayer University of California, Los Angeles
Ariane van der Straten
Ariane van der Straten University of California, San Francisco
Robin J. Shattock
Robin J. Shattock Imperial College London
Pamina M. Gorbach
Pamina M. Gorbach University of California, Los Angeles
Lin Chang
Lin Chang University of California, Los Angeles
Leonid Margolis
Leonid Margolis National Institutes of Health
Alex Carballo-Diéguez
Alex Carballo-Diéguez Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related nursing and healthcare degrees online can open diverse career pathways. Many students begin with foundational programs such as online adn programs for non nurses, which help transition individuals from various backgrounds into nursing roles. These programs are designed to be accessible and flexible, accommodating busy schedules.

Accelerated options like accelerated nursing programs offer a fast-track route for students who already hold a degree and want to move quickly into specialized healthcare fields. These programs emphasize clinical experience, providing practical skills relevant to immunology research and patient care.

Supporting roles in healthcare, such as Licensed Practical Nurses (LPNs), can be a valuable step towards advanced immunology careers. The easiest lpn programs to get into are ideal for individuals seeking entry-level positions with fewer barriers to enrollment, allowing quicker workforce entry.

For advanced practice roles, many students pursue a Family Nurse Practitioner (FNP) degree. The easiest fnp program options provide streamlined paths to becoming a practitioner who can apply immunology knowledge in clinical settings, enhance patient outcomes, and contribute to research.

Best Scientists Citing Peter A. Anton

Trending Scientists

Recently Published Articles